Correlation Between Selenium Levels in Human Tissues and HPV-related Cervical Lesions and Outcomes
NCT06665841 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2024-10-30
Summary
This study investigates the relationship between selenium levels in human tissues and the persistence of HPV (human papillomavirus) infection, particularly focusing on cervical-related lesions. The main objectives are to explore the correlation between selenium levels in different body samples (hair, nails, urine, and blood) and to evaluate selenium's potential protective effects against HPV persistence and its progression to cervical lesions.
Key goals of the study include:
Determining whether non-invasive monitoring (e.g., hair, nails, urine) can accurately reflect blood selenium levels.
Understanding how selenium levels fluctuate in women with persistent HPV infection, and whether selenium supplementation can reduce the risk of HPV-related cervical disease progression.
Exploring selenium's role in enhancing immune function, especially in older adults, to help clear HPV infection.
By recruiting volunteers for selenium level testing and tracking HPV-positive women over time, this research aims to provide evidence on the effectiveness of selenium in preventing cervical cancer progression and potentially clearing HPV infections.
Conditions
- Cervical Intraepithelial Neoplasia (CIN)
- Cervical Cancer
- Persistent HPV Infection
Sponsors & Collaborators
-
Second Affiliated Hospital of Wenzhou Medical University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-11-01
- Primary Completion
- 2027-06-30
- Completion
- 2027-12-31
More Related Trials
-
Neoadjuvant Chemotherapy for Locally Advanced Squamous Cell Cancer of the Head and Neck (SCCHN)
NCT01312350 ·Status: COMPLETED ·Phase: PHASE2
-
Celecoxib in Treating Patients With Head and Neck Cancer That Can Be Removed By Surgery
NCT00357617 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Tertiary Prevention of Head and Neck Cancer With a Dietary Intervention
NCT02869399 ·Status: COMPLETED ·Phase: NA
-
A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papilloma Virus (HPV)- Associated Oropharynx Cancer (OPC)
NCT05307939 ·Status: RECRUITING ·Phase: PHASE2
-
Radiosensitization With Celecoxib and Chemoradiation for Head and Neck Cancer
NCT00581971 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of Chemotherapy Prior to Radiotherapy and Chemotherapy in Patients With HPV Associated Cancer of the Oral Cavity
NCT01525927 ·Status: TERMINATED ·Phase: PHASE2
-
Docetaxel and S-1 Followed By Radiation Therapy and Low-Dose Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck Cancer
NCT00625937 ·Status: UNKNOWN ·Phase: PHASE2
-
Cisplatin Based Chemoradiation v.s Radiotherapy for Cervical Cancer and With Clinically Defined Good Prognosis
NCT00846508 ·Status: UNKNOWN ·Phase: PHASE3
-
Risk-adapted Therapy in HPV+ Oropharyngeal Cancer Using Circulating Tumor (ct)HPV DNA Profile - The ReACT Study
NCT04900623 ·Status: RECRUITING ·Phase: PHASE2
-
Tri-weekly Cisplatin Based Chemoradiation in Locally Advanced Cervical Cancer
NCT01561586 ·Status: UNKNOWN ·Phase: PHASE3
-
Celecoxib Through Surgery and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer
NCT04162873 ·Status: TERMINATED ·Phase: PHASE2
-
Tislelizumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer
NCT05588219 ·Status: RECRUITING ·Phase: PHASE2
-
Celecoxib as Adjuvant Biologic Therapy in Patients With Head and Neck and Lung Cancer
NCT00527982 ·Status: TERMINATED ·Phase: PHASE2
-
Immunologic Responses in HPV-Associated Carcinoma for Patients Receiving Chemoradiation
NCT01958515 ·Status: COMPLETED
-
Vorinostat in Combination With Chemoradiation in Locally Advanced HPV Negative HNSCC
NCT05608369 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Prospective Randomized Controlled Study of Radiotherapy and the Concurrent Three-week and Single-week TP Chemotherapy for Advanced Cervical Squamous Cell Carcinoma and the Correlation Between HPV Classification and Sensitivity.
NCT04588090 ·Status: UNKNOWN ·Phase: NA
-
Soy Isoflavones in Preventing Head and Neck Cancer Recurrence in Patients With Stage I-IV Head and Neck Cancer Undergoing Surgery
NCT02007200 ·Status: COMPLETED ·Phase: PHASE2
-
Celecoxib in Treating Patients With Cervical Intraepithelial Neoplasia
NCT00081263 ·Status: COMPLETED ·Phase: PHASE2
-
Gemcitabine in Treating Patients With Persistent or Recurrent Cancer of the Cervix
NCT00006224 ·Status: TERMINATED ·Phase: PHASE2
-
A Multicenter, Prospective, Randomized Trial of Adjuvant Chemotherapy for Early-Stage Cervical Cancer Patients
NCT01755897 ·Status: COMPLETED ·Phase: NA
-
Patients with Human Papillomavirus-associated Head and Neck Cancer for the Discovery of Predictive Biomarkers to Guide Clinical Intervention
NCT06821243 ·Status: RECRUITING
-
Sorafenib Tosylate, Cisplatin, and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
NCT02035527 ·Status: COMPLETED ·Phase: PHASE1
-
Fenretinide in Treating Patients With Cervical Neoplasia
NCT00003075 ·Status: COMPLETED ·Phase: PHASE3
-
Role of Immune Activation in Response of Head and Neck Squamous Cell Carcinoma to Therapy
NCT01358097 ·Status: COMPLETED
-
Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer
NCT03010150 ·Status: RECRUITING